Atrasentan Treatment Results in Clinically Meaningful Proteinuria Reductions in Patients with IgAN
Treatment with atrasentan results in durable and clinically meaningful proteinuria reductions in patients with IgAN receiving optimized standard of care
Format
PNG
Source
Chinook Therapeutics, Inc.